-
Helping Your IT Brand Become a Mighty Brand
You have to develop a strong company identity that’ll make them choose you. Here’s some advice on how to turn your IT brand into a mighty brand.
-
Alliance Exploring Microbiome on Cancer Immunotherapy
A biotechnology company and two research institutes are collaborating on a study of a proposed cancer treatment that targets the microbiome, communities of bacteria in the human body.
-
FDA Clears First Sensor-Pill and App System
The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence.
-
Zymeworks, Janssen in $1.45B Antibody Licensing Deal
Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets.
-
Infographic: Largest Hacker Breaches and Regulation Tech
Among the most visible and challenging regulatory issues for companies is security breaches, where companies’ systems are attacked with valuable data stolen.
-
Math Models to Predict Animal-Borne Disease Outbreaks
A team of ecologists and mathematicians is applying machine learning and statistical models to forecast outbreaks of zoonotic diseases, those spread to humans from animals.
-
Sanofi Acquires Multiple Sclerosis Drug in $800M Deal
Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system.
-
Psychology In Law: How Important Is An Online Presence For A Modern Law Firm?
Online resources are still a relatively new concept in the grand scheme of things, especially for a modern law firm.
-
Cancer Center, Analytics Company Partner on Precision Care
Memorial Sloan Kettering Cancer Center in New York is collaborating with health care analytics company Cota Inc. to offer more precise care strategies for patients.
-
Open-Source Model Devised to Value Medical Technologies
An initiative joining most major health care stakeholders is developing models to calculate the value of medical treatments, with a process described as open and transparent.